Foresight Diagnostics to Present New Data on Foresight CLARITY™ MRD in Early-Stage Breast Cancer at ESMO Congress 2024  

Ultra-sensitive ctDNA detection and monitoring in early-stage breast cancer using PhasED-Seq 

  • Monday, September 16, 2024
  • Presented by Dr. Luc Cabel, investigator at Memorial Sloan Kettering. Dr. Cabel will be present at the poster to take questions from 12:00-1:00pm CET.  
  • Poster #293